We are live on ! Find out more
MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

15 hedge funds and large institutions have $92.1M invested in Mirati Therapeutics, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.49%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$19.5M
2
TCM
Tang Capital Management
California
+$11.6M
3
O
OrbiMed
New York
+$11.3M
4
QF
QVT Financial
New York
+$5.83M
5
RCM
RA Capital Management
Massachusetts
+$5.42M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$30M +$19.5M +1,980,074 New
TCM
2
Tang Capital Management
California
$17.9M +$11.6M +1,181,400 New
O
3
OrbiMed
New York
$17.4M +$11.3M +1,149,332 New
RCM
4
RA Capital Management
Massachusetts
$8.36M +$5.42M +551,723 New
BI
5
BVF Inc
California
$8.26M +$5.36M +545,372 New
QF
6
QVT Financial
New York
$6.79M +$5.83M +592,978 New
B
7
Bailard
California
$1.03M +$668K +68,000 New
OTPPB
8
Ontario Teachers' Pension Plan Board
Ontario, Canada
$593K +$384K +39,115 New
Goldman Sachs
9
Goldman Sachs
New York
$517K +$336K +34,147 New
Deutsche Bank
10
Deutsche Bank
Germany
$432K +$281K +28,627 New
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$356K +$231K +23,523 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$329K +$214K +21,732 New
U
13
UBS
Switzerland
$139K +$90.1K +9,163 New
Wells Fargo
14
Wells Fargo
California
$10K +$6.65K +677 New
TRCT
15
Tower Research Capital (TRC)
New York
$5K +$2.95K +300 New

MRTX Hedge Fund Activity: Q3 2013 in Review

15 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Mirati Therapeutics, Inc. Common Stock (MRTX) for Q3 2013, worth a combined $92.1M.

Buyers outnumbered sellers: 15 funds opened new MRTX positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $19.5M.

  • 15 institutional investors held Mirati Therapeutics, Inc. Common Stock (MRTX) as of Q3 2013, up from 0 in Q2 2013.
  • Funds reported $92.1M of Mirati Therapeutics, Inc. Common Stock stock for Q3 2013.
  • 15 funds opened new Mirati Therapeutics, Inc. Common Stock positions in Q3 2013 and 0 closed out, a net change of +15 holders.
  • The largest Mirati Therapeutics, Inc. Common Stock buyer in Q3 2013 was Baker Bros. Advisors, an estimated $19.5M added.

Based on aggregated 13F filings for Q3 2013.